Evaluation of glioma tumor volume with 18F-fluciclovine positron emission tomography interpreted in combination with MRI, compared with MRI alone: Results from a …
394 Objectives: Gliomas are the most common primary brain tumor in the US and account
for approximately 25% of all brain tumors, and 80% of all malignant brain tumors. 1 The …
for approximately 25% of all brain tumors, and 80% of all malignant brain tumors. 1 The …
Letter regarding “Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group”: 18F-fluciclovine and …
R Kotecha, M Aboian, SA Nabavizadeh… - Neuro …, 2021 - academic.oup.com
Galldiks and colleagues have provided a comprehensive and informative overview of the
potential applications of positron emission tomography (PET) for radiotherapy planning and …
potential applications of positron emission tomography (PET) for radiotherapy planning and …
[HTML][HTML] Diagnostic performance and safety of positron emission tomography using 18F-fluciclovine in patients with clinically suspected high-or low-grade gliomas: a …
T Wakabayashi, T Iuchi, N Tsuyuguchi… - Asia Oceania Journal …, 2017 - ncbi.nlm.nih.gov
Objective (s): The study objective was to assess the diagnostic performance of positron
emission tomography (PET) for gliomas using the novel tracer 18 F-fluciclovine (anti-[18 F] …
emission tomography (PET) for gliomas using the novel tracer 18 F-fluciclovine (anti-[18 F] …
[HTML][HTML] Radiotherapy target volume definition in newly diagnosed high-grade glioma using 18F-FET PET imaging and multiparametric MRI: an inter observer …
B Dissaux, D Mazouz Fatmi, J Ognard, B Allard… - Tomography, 2022 - mdpi.com
Background: The aim of this prospective monocentric study was to assess the inter-observer
agreement for tumor volume delineations by multiparametric MRI and 18-F-FET-PET/CT in …
agreement for tumor volume delineations by multiparametric MRI and 18-F-FET-PET/CT in …
Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials
T Wakabayashi, Y Hirose, K Miyake, Y Arakawa… - Annals of Nuclear …, 2021 - Springer
Objective Glioma is the most common type of central nervous system tumor reported
worldwide. Current imaging technologies have limitations in the diagnosis and assessment …
worldwide. Current imaging technologies have limitations in the diagnosis and assessment …
[PDF][PDF] Diagnostic Performance and Safety of Positron Emission Tomography Using" F-Fluciclovine in Patients with Clinically Suspected High-or Low-grade Gliomas: A …
Y Arakawa, T Sasayama, K Miyake, T Nariai, Y Narita… - sid.ir
Introduction Gliomas are among the most prevalent primary brain tumors, o ccurring in
approximately one in every four patients with primary brain tumors [1]. According to the 2014 …
approximately one in every four patients with primary brain tumors [1]. According to the 2014 …
Safety and effectiveness of18F-fluciclovine PET in adults with recurrent glioma: A retrospective observational study
T Bach-Gansmo, L Michaud, E Parent, A Akintayo… - 2019 - Soc Nuclear Med
496 Objectives: Gliomas are the most common primary brain tumor in the US. 1 Currently,
magnetic resonance imaging (MRI) is used to image gliomas, both for diagnosis and to …
magnetic resonance imaging (MRI) is used to image gliomas, both for diagnosis and to …
Reply to the letter regarding “Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group”: 18F …
N Galldiks, M Niyazi, JC Tonn, KJ Langen - Neuro-oncology, 2021 - academic.oup.com
With great interest, we have read the Letter to the Editor by Kotecha and colleagues
regarding our recent report of the RANO group. 1 In that paper, we provided a summary of …
regarding our recent report of the RANO group. 1 In that paper, we provided a summary of …
[HTML][HTML] [18] F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program
Background and purpose The [18] F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG)
study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed …
study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed …
[HTML][HTML] [18F]Fluciclovine PET discrimination between high- and low-grade gliomas
Background The ability to accurately and non-invasively distinguish high-grade glioma from
low-grade glioma remains a challenge despite advances in molecular and magnetic …
low-grade glioma remains a challenge despite advances in molecular and magnetic …
Related searches
- mri alone image evaluation
- mri alone prospective phase
- prospective phase image evaluation
- suspected glioma tumor resection
- low grade diagnostic performance
- suspected glioma multicenter phase
- suspected glioma surgical planning
- of18f fluciclovine recurrent glioma
- tumor resection multicenter phase
- combination with mri image evaluation
- combination with mri prospective phase